تحميل...
Inhibition of Androgen-Independent Prostate Cancer by Estrogenic Compounds Is Associated with Increased Expression of Immune-Related Genes
The clinical utility of estrogens for treating prostate cancer (CaP) was established in the 1940s by Huggins. The classic model of the anti-CaP activity of estrogens postulates an indirect mechanism involving the suppression of androgen production. However, clinical and preclinical studies have show...
محفوظ في:
المؤلفون الرئيسيون: | , , , , , , , |
---|---|
التنسيق: | Artigo |
اللغة: | Inglês |
منشور في: |
Neoplasia Press Inc.
2006
|
الموضوعات: | |
الوصول للمادة أونلاين: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1715921/ https://ncbi.nlm.nih.gov/pubmed/17032503 |
الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|